Google Übersetzer
Maia Biotechnology, Inc.
About
Maia Biotechnology, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 4 2026
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
Mar 3 2026
MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Mar 2 2026
MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Dec 16 2025
MAIA Biotechnology Announces $1.51 Million Private Placement
Dec 11 2025
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer